{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:34:01Z","timestamp":1791419641534,"version":"4.3.3"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.neurobiolaging.2008.09.016","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T15:02:18Z","timestamp":1227711738000},"page":"1743-1757","source":"Crossref","is-referenced-by-count":75,"title":["Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Ver\u00f3nica Berta","family":"Dorfman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Riudavets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"L\u00f3pez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Miguel","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0006-8993(01)02390-3","article-title":"Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition","volume":"902","author":"Akiyama","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(03)00030-2","article-title":"Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques","volume":"339","author":"Apelt","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(99)00135-4","article-title":"Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques","volume":"263","author":"Bernstein","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","article-title":"An analysis of transformations (with discussion)","volume":"26","author":"Box","year":"1964","journal-title":"J. R. Stat. Soc. B"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410190306","article-title":"A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study","volume":"19","author":"Brun","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neurobiolaging.2004.06.013","article-title":"Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders","volume":"26","author":"Caccamo","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib8","doi-asserted-by":"crossref","first-page":"32185","DOI":"10.1074\/jbc.271.50.32185","article-title":"The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease","volume":"271","author":"Casta\u00f1o","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.neurobiolaging.2005.10.016","article-title":"Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages","volume":"27","author":"Cullen","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/34910","article-title":"Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein","volume":"391","author":"De Strooper","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib12","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1212\/WNL.59.3.398","article-title":"Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease","volume":"59","author":"Delacourte","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib13","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1523\/JNEUROSCI.20-17-06452.2000","article-title":"Aging increased amyloid \u03b2 peptide and caused amyloid plaques in brain of old APP\/V717I transgenic mice by a different mechanism than mutant presenilin 1","volume":"20","author":"Dewachter","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib14","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid betaprotein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-0102(02)00015-9","article-title":"Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology","volume":"43","author":"Fukami","year":"2002","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib16","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuroscience.2006.08.027","article-title":"High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain","volume":"143","author":"G\u00fcntert","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib18","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0166-2236(00)01990-1","article-title":"Cholesterol, A beta and Alzheimer's disease","volume":"24","author":"Hartmann","year":"2001","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib19","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1523\/JNEUROSCI.22-23-10083.2002","article-title":"Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease","volume":"22","author":"Hartman","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.286.5441.916","article-title":"The presenilins in Alzheimer's disease\u2014proteolysis holds the key","volume":"286","author":"Haass","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib21","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain Abeta by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-7091-6139-5_1","article-title":"Vascular-ischemic dementia: an update","volume":"62","author":"Jellinger","year":"2002","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-006-0099-z","article-title":"The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison","volume":"112","author":"Jeynes","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib24","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/bi015685+","article-title":"APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques","volume":"41","author":"Kalback","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib25","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1074\/jbc.M609168200","article-title":"Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib26","doi-asserted-by":"crossref","first-page":"22599","DOI":"10.1016\/S0021-9258(17)31688-5","article-title":"Inducible expression and cellular localization of insulin-degrading enzyme in a stably transfected cell line","volume":"269","author":"Kuo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib27","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1074\/jbc.M007859200","article-title":"Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains","volume":"276","author":"Kuo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib28","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/01.jnen.0000235853.70092.ba","article-title":"Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology","volume":"65","author":"Leal","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm1096-1146","article-title":"The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology","volume":"2","author":"Lemere","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib31","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.2111584","volume":"248","author":"Levy","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-006-0077-5","article-title":"Characterization of Abeta11-40\/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease","volume":"112","author":"Liu","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib33","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00702-006-0592-5","article-title":"Alois Alzheimer revisited: differences in origin of the disease carrying his name","volume":"113","author":"Maurer","year":"2006","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","article-title":"Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy","volume":"65","author":"Miners","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib36","doi-asserted-by":"crossref","first-page":"23221","DOI":"10.1074\/jbc.M300276200","article-title":"Differential degradation of amyloid beta genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme","volume":"278","author":"Morelli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib37","doi-asserted-by":"crossref","first-page":"56004","DOI":"10.1074\/jbc.M407283200","article-title":"Insulin degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy","volume":"279","author":"Morelli","year":"2004","journal-title":"Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology","volume":"61","author":"Pappolla","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007527721160","article-title":"Degradation of soluble amyloid \u03b2-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains","volume":"25","author":"Perez","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib40","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neurobiolaging.2004.09.003","article-title":"Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease","volume":"26","author":"Poirier","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib41","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.90.22.10836","article-title":"beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease","volume":"90","author":"Roher","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03402043","article-title":"Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease","volume":"9","author":"Roher","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib43","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1001\/archneur.1997.00550220036011","article-title":"Genetic testing for Alzheimer disease. Practical and ethical issues","volume":"54","author":"Roses","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib44","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2000.tb05554.x","article-title":"Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein","volume":"924","author":"Selkoe","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib46","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1471-4159.2003.01818.x","article-title":"Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach","volume":"85","author":"Sergeant","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib47","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib48","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/gps.1384","article-title":"Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease\u2014a neuropathological study","volume":"20","author":"Sj\u00f6beck","year":"2005","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1332.001","article-title":"Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration","volume":"1035","author":"Turner","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib50","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1073\/pnas.84.16.5991","volume":"84","author":"van Duinen","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbrc.2003.09.003","article-title":"Oxidized neprilysin in aging and Alzheimer's disease brains","volume":"310","author":"Wang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.jnen.0000199599.63204.6f","article-title":"Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease","volume":"65","author":"Webster","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib54","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/19077","article-title":"Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity","volume":"398","author":"Wolfe","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(00)01675-X","article-title":"Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide","volume":"297","author":"Yakoshima","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2008.09.016_bib56","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neurobiolaging.2006.05.001","article-title":"Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease","volume":"6","author":"Zhao","year":"2007","journal-title":"Neurobiol. Aging"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008003515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458008003515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T17:22:21Z","timestamp":1738689741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458008003515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0197458008003515"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.09.016","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}